<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Higa N</submitter><funding>Breast Cancer Research Foundation (BCRF)</funding><funding>U.S. Department of Health &amp; Human Services | NIH | National Cancer Institute (NCI)</funding><pagination>309</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12290075</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Heterogeneous circulating tumor cells (CTCs) have been implicated in the formation of new metastases. However, circulating cells expressing both tumor and immune cell proteins are often dismissed as insignificant findings in CTC studies.&lt;h4>Methods&lt;/h4>Two non-contemporaneous blood samples from a metastatic breast cancer patient were analyzed using an enrichment-free platform to identify canonical, epithelial-only CTCs (CD45-/cytokeratin + , epi.CTCs) and CD45 + /cytokeratin+ immune-like CTCs (im.CTCs). Single cells from both samples were subjected to copy number and protein expression profiling. A cohort of 36 metastatic breast cancer patients was then analyzed to search for additional cases with im.CTCs.&lt;h4>Results&lt;/h4>Here, we identified and characterized a population</pubmed_abstract><journal>Communications medicine</journal><pubmed_title>Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer.</pubmed_title><pmcid>PMC12290075</pmcid><funding_grant_id>BCRF-16-189</funding_grant_id><funding_grant_id>5P30CA014089-40</funding_grant_id><funding_grant_id>BCRF-18-089</funding_grant_id><pubmed_authors>Hicks J</pubmed_authors><pubmed_authors>Kolatkar A</pubmed_authors><pubmed_authors>Riker AI</pubmed_authors><pubmed_authors>Tafra L</pubmed_authors><pubmed_authors>Limb A</pubmed_authors><pubmed_authors>Rivera A</pubmed_authors><pubmed_authors>Tweed CK</pubmed_authors><pubmed_authors>Shriver CD</pubmed_authors><pubmed_authors>Nevarez R</pubmed_authors><pubmed_authors>Lee Y</pubmed_authors><pubmed_authors>Higa N</pubmed_authors><pubmed_authors>Hennes V</pubmed_authors><pubmed_authors>Kuhn P</pubmed_authors><pubmed_authors>Perkins JG</pubmed_authors></additional><is_claimable>false</is_claimable><name>Simultaneous expression of epithelial and immune cell markers in circulating tumor cells identified in patients with stage 4 breast cancer.</name><description>&lt;h4>Background&lt;/h4>Heterogeneous circulating tumor cells (CTCs) have been implicated in the formation of new metastases. However, circulating cells expressing both tumor and immune cell proteins are often dismissed as insignificant findings in CTC studies.&lt;h4>Methods&lt;/h4>Two non-contemporaneous blood samples from a metastatic breast cancer patient were analyzed using an enrichment-free platform to identify canonical, epithelial-only CTCs (CD45-/cytokeratin + , epi.CTCs) and CD45 + /cytokeratin+ immune-like CTCs (im.CTCs). Single cells from both samples were subjected to copy number and protein expression profiling. A cohort of 36 metastatic breast cancer patients was then analyzed to search for additional cases with im.CTCs.&lt;h4>Results&lt;/h4>Here, we identified and characterized a population</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jul</publication><modification>2026-03-15T17:17:49.942Z</modification><creation>2025-08-13T03:04:38.363Z</creation></dates><accession>S-EPMC12290075</accession><cross_references><pubmed>40707771</pubmed><doi>10.1038/s43856-025-01024-0</doi></cross_references></HashMap>